Identification of biomarkers associated with CD8+ T cells in rheumatoid arthritis and their pan-cancer analysis.

Introduction: Rheumatoid arthritis (RA), a prevailing chronic progressive autoimmune disease, seriously affects the patient's quality of life. However, there is still a lack of precise treatment and management methods in clinical practice. Previous studies showed that CD8+ T cells take a lead in the progression of RA.